Anticancer Activity of Bacterial Proteins and Peptides

Area of Science:

• Microbiology
• Biochemistry
• Pharmacology

Background:

• Cancer remains a leading cause of death globally, with chemotherapy facing challenges like side effects and drug resistance.
• Bacterial-derived proteins and peptides represent a promising avenue for novel anticancer drug discovery.
• Existing bacterial compounds like actinomycin D and diphtheria toxin are already utilized in cancer therapy.

Purpose of the Study:

• To review current literature on the anticancer activities of bacterial proteins and peptides.
• To explore diverse classes of bioactive compounds, including antibiotics, bacteriocins, enzymes, toxins, and nonribosomal peptides (NRPs).
• To specifically investigate less-understood compounds from marine sediment bacteria.

Main Methods:

• Comprehensive literature search and review of scientific articles.
• Identification and categorization of bacterial proteins and peptides with reported antitumor properties.
• Analysis of existing and emerging therapeutic applications of these compounds.

Main Results:

• Identified 37 distinct bacterial chemical compounds or groups exhibiting antitumor properties.
• Highlighted various classes of compounds including antibiotics, bacteriocins, enzymes, NRPs, toxins (e.g., azurin, p28, Entap, Pep27anal2).
• Emphasized the potential of compounds derived from marine sediment bacteria.

Conclusions:

• Bacterial proteins and peptides are a rich source of potential anticancer agents.
• Further research into these compounds, particularly those from marine environments, could lead to new cancer treatments.
• These bioactive molecules offer a promising alternative or adjunct to conventional chemotherapy.